Particle.news
Health ❯Mental Health ❯Depression
Depression Clinical Trials Neurotransmitters Stigma Senators Drug Development Antidepressants Drug Development Drug Approval U.S. Foreign Policy
More than half of cancer patients in the Phase II trial experienced sustained remission of depressive symptoms with a single dose of psilocybin, prompting researchers to launch repeat-dose studies.
